Stockreport

Roche's CT-388 Obesity Data Tests New Growth Pillar Potential [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche Holding (SWX:ROG) reported significant weight loss results from Phase II trials of its dual GLP-1/GIP obesity candidate CT-388. The company plans protocol adjus [Read more]